Obesity Trial, Recruiting NCT06511297 Sponsor: Thomas Scherer Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06511297
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The trial has five separate groups, each with different requirements:

  • Group 1 – Lean, young adults: People aged 18–35 with a BMI between 18.5 and 24.9 (maintained for at least 12 months)
  • Group 2 – Overweight, young adults: People aged 18–35 with a BMI of 28 or higher (maintained for at least 12 months)
  • Group 3 – Lean, older adults: People aged 60 or older with a BMI between 18.5 and 24.9 (maintained for at least 3 years)
  • Group 4 – Overweight, older adults: People aged 60 or older with a BMI of 28 or higher (maintained for at least 3 years), divided into two subgroups: those who have a history of heart attack, coronary artery disease, stroke, peripheral artery disease, or mild-to-moderate heart failure (Subgroup A), and those with none of these conditions (Subgroup B)
  • Group 5 – Nonagenerians: People aged 90 or older with a BMI of 18.5 or higher (maintained for at least 3 years)

Who may not be able to join:

For Groups 1 and 2 (young adults — lean and overweight):

  • People who exercise at moderate to high intensity more than 5 times per week
  • People following special diets such as a ketogenic diet or time-restricted eating
  • People with significant hormone or metabolism disorders
  • People with claustrophobia (fear of enclosed spaces, such as an MRI machine)
  • People who use illicit drugs or drink more than 15 alcoholic drinks per week
  • People with heart failure, cardiovascular disease, conditions requiring immune-suppressing medications, ongoing inflammatory diseases, or active cancer
  • People with metal implants that are not compatible with a 3-Tesla MRI scan
  • People who are pregnant or breastfeeding
  • Group 2 only: People currently using weight-loss medications such as GLP-1 drugs (e.g. semaglutide), naltrexone, or bupropion

For Groups 3 and 4 (older adults — lean and overweight):

  • People following special diets such as a ketogenic diet or time-restricted eating
  • People with diabetes or an overactive or underactive thyroid
  • People with claustrophobia
  • People who use illicit drugs or drink more than 15 alcoholic drinks per week
  • People with metal implants that are not compatible with a 3-Tesla MRI scan
  • People who had heart failure, cardiovascular disease, immune-suppressing treatment, inflammatory disease, or active cancer before the age of 35
  • People with a life-threatening condition or life expectancy of less than one year, or any condition that could affect their safety or ability to participate
  • Group 3 only: People who exercise at moderate to high intensity more than 5 times per week
  • Group 3 only: People with severe cardiovascular disease, advanced heart failure, or significantly reduced heart pumping function
  • Group 4 only: People currently using weight-loss medications such as GLP-1 drugs, naltrexone, or bupropion

For Group 5 (people aged 90 and over):

  • People with claustrophobia
  • People with significant cognitive impairment (such as severe memory or thinking problems) that would affect their ability to take part
  • People with metal implants that are not compatible with a 3-Tesla MRI scan
  • People with a life-threatening condition or life expectancy of less than one year, or any condition that could affect their safety or ability to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Thomas Scherer
Registry
ClinicalTrials.gov
Start date
5 May 2025
Est. completion
1 January 2035

Where this trial is recruiting

🇦🇹 Austria

Primary endpoints

Biological age: Epigenetic and clinical clocks

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov